Aarti Drugs Limited (ADL) engages in the manufacture and sale of bulk drugs and its intermediates in India and internationally. The company offers various active pharmaceutical ingredients in the therapeutic categories, such as anti inflammatory, cardioprotectant, antidiarrhoeals/antiprotozoals, antifungals, antiarthritis/osteoporosis, antihistamine, antibiotic, antidiabetic, alzheimers treatment, antihypertensive, antiBPH, sedative, traquilizar, antipsychotic, and vitamins. ADL also provides pharmaceutical ingredients that primarily include 2 methyl 5 nitro imidazoles, 2 methyl imidazoles, imidazoles, 1 butyl imidazoles, 2 ethyl imidazoles, 2,6 dichloro phenylamines, diclofenac free acids, 1-2,6, Dichlorophenyl C2-2 Indolinones, 1 methyl amine 1 methyl thio C2 nitro ethane, methyl nicotinates/ethyl nicotinates/benzyl nicotinates, 2 phenoxy anilines, 2 phenoxy methane sulphamides, 4 sulphonamidophenylhydrazine hydrochlorides, tartrate of methyl alpha amino acetates, and methyl alpha C acetate hydrochloride salts; and various other ingredients for irbesartan, zolpidem tartrate, tamsulosin HCL, raloxifene, leflunomide, and levocetirizine. In addition, Aarti Drugs offers steroids comprising hydrocortisone sodium succinate sterile, hydrocortisone acetate, and hydrocortisone hemisuccinate, as well as various specialty chemicals. The company was founded in 1984 and is based in Mumbai, India.
Legal Address
Plot No. 198, M.I.D.C.,, Tarapur,
Thane; Maharashtra;
Postal Code: 401506
Contact Details: Purchase the Aarti Drugs Ltd. report to view the information.
Website: http://www.aartidrugs.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service